Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions

US9656079B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9656079-B2
Application numberUS-56591009-A
CountryUS
Kind codeB2
Filing dateSep 24, 2009
Priority dateOct 26, 2000
Publication dateMay 23, 2017
Grant dateMay 23, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method and apparatus are used to provide therapy to a patient experiencing ventricular dysfunction or heart failure. At least one electrode is located in a region associated with nervous tissue, such as nerve bundles T1-T4, in a patient's body. Electrical stimulation is applied to the at least one electrode to improve the cardiac efficiency of the patient's heart. One or more predetermined physiologic parameters of the patient are monitored, and the electrical stimulation is adjusted based on the one or more predetermined physiologic parameters.

First claim

Opening claim text (preview).

The invention claimed is: 1. An apparatus for treating a patient to improve cardiac performance and efficiency of the patient's heart, the apparatus comprising: at least one electrode adapted to be located in a region associated with nervous tissue in a patient; means for monitoring one or more physiologic parameters of the patient; means for automatically applying electrical stimulation via the at least one electrode to improve balance of a neuro-endocrinological system of the patient in response to the one or more physiologic parameters of the patient; and means for delivering a pacing therapy to the patient's heart of a type that improves cardiac output, wherein said pacing therapy consists of a cardiac resynchronization therapy; and means for adjusting the parameters of electrical stimulation while it is being delivered responsive to the one or more physiological parameters of the patient as monitored during contemporaneous delivery of the pacing therapy. 2. The apparatus of claim 1 wherein delivery of the pacing therapy comprises delivering the pacing therapy with parameters altered from a previously delivered pacing therapy in conjunction with applying the electrical stimulation. 3. The apparatus of claim 1 wherein the monitoring means comprises a pressure sensor. 4. The apparatus of claim 3 wherein the monitoring means comprises a pressure sensor adapted for a cardiac location. 5. The apparatus of claim 4 wherein the monitoring means comprises means for determining the patient's diastolic pressure.

Assignees

Inventors

Classifications

  • for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy · CPC title

  • Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9656079B2 cover?
A method and apparatus are used to provide therapy to a patient experiencing ventricular dysfunction or heart failure. At least one electrode is located in a region associated with nervous tissue, such as nerve bundles T1-T4, in a patient's body. Electrical stimulation is applied to the at least one electrode to improve the cardiac efficiency of the patient's heart. One or more predetermined ph…
Who is the assignee on this patent?
Hill Michael R S, King Gary W, Mullen Thomas J, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61N1/36114. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).